Latest news on Laboratorytalk categorised by supplier
Kalorama Information
Address:
38 East 29th Street 6th Floor
New York
10016
United States
Telephone: (United States) +1 212 807 2660
http://www.kaloramainformation.com
Our RSS feed for news from Kalorama Information
Request to receive our free email newsletter each week
Listing of all 7 news releases from Kalorama Information:
Cancer diagnostics to reach $7.4 billion by 2009
Despite the high price tag and hesitation by payer groups, the demand for in vitro diagnostic (IVD) cancer tests will continue to increase as the annual incidence of new cancer cases soars
News from Kalorama Information (31 October 2005)
Double-digit growth for antivirals
Growth rates recently enjoyed by the world market for prescription antiviral medications will peak in the 2005-2006 period at nearly 17% before falling to more modest levels by the end of the decade
News from Kalorama Information (27 June 2005)
Analytical microchip market to enter growth phase
US market for analytical microchip technologies in the life sciences is poised to experience explosive growth in the next five years
News from Kalorama Information (20 June 2005)
Cardiovascular drug market to top $100bn by 2008
Study examines eight major segments of the cardiovascular drug market, considers epidemiology and demographics, covers major trends, and provides competitive market share for the major players
News from Kalorama Information (13 June 2005)
Recombinant products drive infertility drug market
Market research study forecasts steady growth in the infertility management market, which is dominated by a few major players and is highly competitive
News from Kalorama Information (16 May 2005)
In-silico modelling leads growth in drug discovery
The still nascent in-silico modelling tools segment promises to provide valuable structural, screening, and validation information at a fraction of the cost of traditional methods
News from Kalorama Information (12 May 2005)
Managing diabetes and its complications
Market report finds that uneven growth and dynamic conditions prevail in the world's top markets for diabetes monitoring and therapeutic products
News from Kalorama Information (30 March 2005)
